Bringing Hope to a Young Life: Advanced Leukemia Treatment at Bioocus Medical Group

Understanding B-ALL

B-ALL is an aggressive form of leukemia that affects B lymphocytes, predominantly striking children and adolescents. Shakib was diagnosed with CD10-positive B-ALL on July 20, 2023, at King Hussein Cancer Center (KHCC). Despite undergoing initial induction, consolidation, and re-intensification treatments, his condition relapsed on August 15, 2024, with a bone marrow examination revealing 90% blasts. Determined to fight this challenging disease, Shakib and his family turned to Bioocus Medical Group for advanced care.

 
A Breakthrough Solution: CD22 CAR-T Therapy

Following a thorough evaluation by our expert team, we recommended CD22-targeted Chimeric Antigen Receptor T-cell (CAR-T) therapy—a revolutionary Immunotherapy tailored to Shakib’s condition. This treatment leverages his own immune system to combat leukemia and includes the following steps:

1. T-Cell Collection: Shakib’s T-cells are harvested through leukapheresis, a process that isolates these vital immune cells from his blood.
2. Genetic Modification: In our state-of-the-art laboratories, the T-cells are engineered to express CARs that specifically target CD22, an antigen highly                expressed on B-ALL cells.
3. Infusion: The modified CAR-T cells are infused back into Shakib, where they seek out and destroy leukemia cells with precision.
 
This personalized approach offers renewed hope for patients like Shakib, where conventional therapies have fallen short. The treatment spans 6-8 weeks, supported by our advanced facilities and expert care, with adjustments made based on his immune response.

 
Our Expertise and Holistic Care

Bioocus Medical Group stands at the forefront of Cancer Treatment, operating four CGT centers in top oncology and hematology hospitals in Beijing and Tianjin. Shakib’s treatment at our Tianjin center reflects our dedication to excellence. Our multidisciplinary team—comprising oncologists, immunologists, and cell therapy specialists—brings unmatched expertise to every case. We prioritize patient safety, closely monitoring for side effects like cytokine release syndrome and providing prompt, expert management.
Beyond medical innovation, we offer comprehensive care, from pre-treatment assessments to post-therapy follow-ups, ensuring a seamless experience. For international patients like Shakib, we provide culturally sensitive support, including translation services and assistance with logistics, helping families feel confident and supported throughout their journey.

 
A Global Mission of Hope

Shakib’s journey underscores our mission to serve patients globally, reflecting the trust families place in our advanced therapies and compassionate care. As he progresses through treatment, our team remains committed to optimizing his plan, adapting to his unique needs, and exploring every avenue to defeat this relentless disease.